0001209191-15-028519.txt : 20150323
0001209191-15-028519.hdr.sgml : 20150323
20150323160541
ACCESSION NUMBER: 0001209191-15-028519
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150320
FILED AS OF DATE: 20150323
DATE AS OF CHANGE: 20150323
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PERKINELMER INC
CENTRAL INDEX KEY: 0000031791
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 042052042
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0102
BUSINESS ADDRESS:
STREET 1: 940 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781 663 5776
MAIL ADDRESS:
STREET 1: 940 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: EG&G INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: EDGERTON GERMESHAUSEN & GRIER INC
DATE OF NAME CHANGE: 19670626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Corbett James
CENTRAL INDEX KEY: 0001359052
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-05075
FILM NUMBER: 15719260
MAIL ADDRESS:
STREET 1: 940 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 024511457
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-03-20
0
0000031791
PERKINELMER INC
PKI
0001359052
Corbett James
940 WINTER STREET
WALTHAM
MA
02451
0
1
0
0
Please See Remarks
Common Stock
2015-03-20
4
M
0
2087
26.145
A
28502
D
Common Stock
2015-03-20
4
M
0
1319
33.87
A
29821
D
Common Stock
2015-03-20
4
S
0
5157
50.228
D
24664
D
NQ Stock Option (right to buy)
26.145
2015-03-20
4
M
0
2087
0.00
D
2019-02-07
Common Stock
2087
4175
D
NQ Stock Option (right to buy)
33.87
2015-03-20
4
M
0
1319
0.00
D
2020-02-05
Common Stock
1319
9232
D
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Corbett on February 18, 2015.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $49.970 to $50.270. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
This option became exercisable in three equal annual installments beginning on February 7, 2013, which was the first anniversary of the date on which the option was granted.
This option became exercisable in three equal annual installments beginning on February 5, 2014, which was the first anniversary of the date on which the option was granted.
Senior Vice President and President, Human Health
/s/ John L. Healy (POA on file) for James Corbett
2015-03-23